{"entity":{"id":"nct07605728","kind":"trial","name":"Probiotics for Abemaciclib-Induced Abdominal Discomfort.","aka":[],"tldr":"A phase 2 trial of an investigational treatment in advanced solid tumours, run by Leeuwenhoek Laboratories Co. Ltd., now recruiting.","summary":"Probiotics for Abemaciclib-Induced Abdominal Discomfort. is a phase 2 interventional study registered as NCT07605728 by Leeuwenhoek Laboratories Co. Ltd., with 80 participants planned, started 2026-05-15 and due to reach its primary completion in 2029-06-30.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07605728","url":"https://clinicaltrials.gov/study/NCT07605728"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07605728","phase":"2","setting":"A Randomized, Phase II Study About Probiotics to Alleviate Abemaciclib-induced Abdominal Discomfort Under Standard Anti-diarrhea Drug Loperamide and Changes of Metabolic Factors in Blood.","sponsor":"Leeuwenhoek Laboratories Co. Ltd.","enrolled":80,"outcomes":[]},"route":"/trials/nct07605728/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}